Author

Jenna Elder

Observed name: J. Elder

OpenAlex ID: A5000447305

Evaluation of Intravenous Peramivir for Treatment of Influenza in Hospitalized Patients

2014 · M. D. de Jong, M. G. Ison, et al. · Clinical Infectious Diseases · 118

Clinical Experience in Adults and Children Treated with Intravenous Peramivir for 2009 Influenza A (H1N1) Under an Emergency IND Program in the United States

2011 · Jaime E. Hernandez, Raghavendra Adiga, et al. · Clinical Infectious Diseases · 93

Dusquetide: A novel innate defense regulator demonstrating a significant and consistent reduction in the duration of oral mucositis in preclinical data and a randomized, placebo-controlled phase 2a clinical study

2016 · Mahesh Kudrimoti, Amarintha Curtis, et al. · Journal of Biotechnology · 73

Intravenous Peramivir for Treatment of Influenza in Hospitalized Patients

2013 · Michael G Ison, Joseph Fraiz, et al. · Antiviral Therapy · 42

Assessing teratogenicity of antiretroviral drugs: monitoring and analysis plan of the Antiretroviral Pregnancy Registry

2004 · Deborah L. Covington, Hugh Tilson, et al. · Pharmacoepidemiology and Drug Safety · 38

A Phase 2 Proof‐of‐Concept, Randomized, Placebo‐Controlled Trial of CX ‐8998 in Essential Tremor

2021 · Spyros Papapetropoulos, Margaret S. Lee, et al. · Movement Disorders · 31

Single dose Peramivir for the Treatment of Acute Seasonal Influenza: Integrated Analysis of Efficacy and Safety from Two Placebo-Controlled Trials

2014 · Richard Whitley, Alan Laughlin, et al. · Antiviral Therapy · 26

Dusquetide: Reduction in oral mucositis associated with enduring ancillary benefits in tumor resolution and decreased mortality in head and neck cancer patients

2017 · Mahesh Kudrimoti, Amarinthia Curtis, et al. · Biotechnology Reports · 21

A pooled analysis of 3 large multicenter trials confirms a survival advantage for NPM1 mut AML in MRD neg remission after intensive induction

2025 · Konstanze Döhner, Hartmut Döhner, et al. · HemaSphere · 4

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Entospletinib in Combination with Intensive Induction and Consolidation Chemotherapy in Adults with Newly Diagnosed N ucleophosmin 1-mutated Acute Myeloid Leukemia

2021 · John C. Byrd, Jorge E. Cortes, et al. · Blood · 3

Efficacy and Safety of CX-8998 in T-CALM, a Randomized, Double-Blind, Placebo-Controlled, Phase 2a Trial in Participants With Essential Tremor: Subgroup Analysis by Baseline Tremor Severity (1842)

2020 · Hyder A. Jinnah, Spyros Papapetropoulos, et al. · Neurology · 1

Analysis of Patient-Level Data from 3 Cooperative Group Trials Confirms a Survival Advantage for NPM1m Patients Achieving MRD-Negative CR after Intensive Induction

2022 · Konstanze Döhner, Hartmut Döhner, et al. · Blood

827The efficacy of single dose peramivir in acute uncomplicated influenza: an integrated subject-level meta-analysis

2014 · Richard Whitley, Phil Collis, et al. · Open Forum Infectious Diseases

1169Peramivir Safety in Hospitalized Influenza

2014 · Sylvia Dobo, Jenna Elder, et al. · Open Forum Infectious Diseases

Works count: 14

Citation count: 450

H-index: 8

I10-index: 8